These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9868597)

  • 1. Monoclonal antibody recognizing a core epitope on mucin.
    Devine PL; Quin RJ; Shield PW; Liew YW; Sheehan JK; Thornton DJ
    Dis Markers; 1998 Oct; 14(2):99-112. PubMed ID: 9868597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies reacting with the MUC2 mucin core protein.
    Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
    Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast tumor-associated epitope defined by monoclonal antibody 3E1.2 is an O-linked mucin carbohydrate containing N-glycolylneuraminic acid.
    Devine PL; Clark BA; Birrell GW; Layton GT; Ward BG; Alewood PF; McKenzie IF
    Cancer Res; 1991 Nov; 51(21):5826-36. PubMed ID: 1718585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies recognising sialyl-Tn: production and application to immunochemistry.
    Devine PL; Birrell GW; Quin RJ; Shield PW
    Dis Markers; 1995 Aug; 12(3):175-86. PubMed ID: 8590544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.
    Kjeldsen T; Clausen H; Hirohashi S; Ogawa T; Iijima H; Hakomori S
    Cancer Res; 1988 Apr; 48(8):2214-20. PubMed ID: 2450649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells.
    Medina M; Vélez D; Asenjo JA; Egea G; Real FX; Gil J; Subiza JL
    Cancer Res; 1999 Mar; 59(5):1061-70. PubMed ID: 10070964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tn human monoclonal antibodies generated following active immunization with partially desialylated ovine submaxillary mucin.
    O'Boyle KP; Wright K
    Hum Antibodies Hybridomas; 1994; 5(1-2):25-31. PubMed ID: 7532023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody directed against colon cancer mucin has high specificity for malignancy.
    Siddiki B; Ho JJ; Huang J; Byrd JC; Lau E; Yuan M; Kim YS
    Int J Cancer; 1993 May; 54(3):467-74. PubMed ID: 7685327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
    Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
    Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second generation anti-MUC1 peptide monoclonal antibodies.
    Xing PX; Prenzoska J; Quelch K; McKenzie IF
    Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells.
    Nuti M; Turchi V; Rughetti A; Viacava P; Masci AM; Castagna M; Frati L
    Int J Biol Markers; 1992; 7(2):71-9. PubMed ID: 1378874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas.
    Girling A; Bartkova J; Burchell J; Gendler S; Gillett C; Taylor-Papadimitriou J
    Int J Cancer; 1989 Jun; 43(6):1072-6. PubMed ID: 2471698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and characterization of monoclonal antibodies to purified deglycosylated cystic fibrosis respiratory mucin: evidence for the presence of four immunologically distinct epitopes.
    Desai VC; Naziruddin B; Graves DC; Reyes de la Rocha S; Sachdev GP
    Hybridoma; 1991 Apr; 10(2):285-96. PubMed ID: 1714878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.
    Huang J; Byrd JC; Siddiki B; Yuan M; Lau E; Kim YS
    Dis Markers; 1992; 10(2):81-94. PubMed ID: 1281060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
    Bashford JL; Robins RA; Price MR
    Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncofetal mucin M1 epitope family: characterization and expression during colonic carcinogenesis.
    Bara J; Gautier R; Mouradian P; Decaens C; Daher N
    Int J Cancer; 1991 Jan; 47(2):304-10. PubMed ID: 1988372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MUC1 and MUC2 mucins by human tumor cell lines.
    Devine PL; Birrell GW; Whitehead RH; Harada H; Xing PX; McKenzie IF
    Tumour Biol; 1992; 13(5-6):268-77. PubMed ID: 1283926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of new pancreatic cancer-reactive monoclonal antibodies directed against purified mucin.
    Ho JJ; Bi N; Yan PS; Yuan M; Norton KA; Kim YS
    Cancer Res; 1991 Jan; 51(1):372-80. PubMed ID: 1703039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
    Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
    Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.